| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8962969 | Diabetes & Metabolic Syndrome: Clinical Research & Reviews | 2019 | 16 Pages |
Abstract
The study showed that low dose of pioglitazone is an effective, safe and inexpensive method in reducing of proteinuria in type2 diabetic patients with nephropathy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Pejman pourshabanan, Ali Momeni, Leila Mahmoudnia, Soleiman Kheiri,